Physician

Allison L Engelbrecht, A.R.N.P.

According to 2025 Medicare claims, Allison Engelbrecht, A.R.N.P. (NPI: 1366605347) practices nurse practitioner in the Decatur, IL market, with the plurality of this provider's patient population coming from Macon, IL. This provider's primary affiliated billing organization is VITALSKIN MEDICAL GROUP IL PLLC (NPI: 1063030252; TIN: 851790842) and primary practice location at 62526-3269. Engelbrecht is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Engelbrecht's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,109 traditional Medicare patients, billed 3,891 HCPCS/CPT codes, and received $123,817 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 893 prescription claims across 359 beneficiaries totaling $604,418 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 90 records totaling $1,402. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $40,278 to $604,418. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$62K$124K2022 Medicare payment: $79,081 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $113,895 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $123,817 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20227131,971$79,081
20231,1043,640$113,895
20241,1093,891$123,817

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$302K$604K2015 Drug cost: $40,278 (USD; Tot_Drug_Cst)2016 Drug cost: $30,232 (USD; Tot_Drug_Cst)2017 Drug cost: $58,454 (USD; Tot_Drug_Cst)2018 Drug cost: $62,285 (USD; Tot_Drug_Cst)2019 Drug cost: $80,063 (USD; Tot_Drug_Cst)2020 Drug cost: $119,300 (USD; Tot_Drug_Cst)2021 Drug cost: $145,415 (USD; Tot_Drug_Cst)2022 Drug cost: $185,710 (USD; Tot_Drug_Cst)2023 Drug cost: $504,446 (USD; Tot_Drug_Cst)2024 Drug cost: $604,418 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015172366$40,278
2016207452$30,232
2017177423$58,454
2018212464$62,285
2019245521$80,063
2020218548$119,300
2021232563$145,415
2022222524$185,710
2023313737$504,446
2024359893$604,418

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more309364$62
11102Biopsy of related skin growth, first growth166179$46
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more771943$44
17000Destruction of precancer skin growth, 1 growth392476$28
17003Destruction of precancer skin growth, 2-14 growths2921,318$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab401,344$182,266
Dupixent SyringeDupilumab24672$89,723
Doxycycline Ir-DrDoxycycline Monohydrate12360$6,557
MetronidazoleMetronidazole401,242$3,495
Clobetasol PropionateClobetasol Propionate561,531$2,466

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.90$1,402UCB, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Allison L. Engelbrecht, A.R.N.P.?

Tedicare shows public-source Medicare data for Allison L. Engelbrecht, A.R.N.P. (NPI 1366605347), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allison L. Engelbrecht, A.R.N.P. have ACO affiliation data?

Allison L. Engelbrecht, A.R.N.P. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Allison L. Engelbrecht, A.R.N.P.?

Allison L. Engelbrecht, A.R.N.P. is linked to VITALSKIN MEDICAL GROUP IL PLLC (billing NPI 1063030252) in the available physician profile data.

Does Allison L. Engelbrecht, A.R.N.P. have Open Payments data?

Allison L. Engelbrecht, A.R.N.P. has 90 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.